# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001108205-23-000036
Filing Date
2023-04-11
Accepted
2023-04-11 16:38:17
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | curis_2022proxynoticeandac.htm | DEFA14A | 9783
2 |  | proxynoticeandaccesscardv2.jpg | GRAPHIC | 531085
3 |  | proxynoticeandaccesscardv2a.jpg | GRAPHIC | 390504
| Complete submission text file | 0001108205-23-000036.txt |  | 1279641

Mailing Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING C, SUITE 500 LEXINGTON MA 02421 617-503-6500
CURIS INC (Filer) CIK: 0001108205 (see all company filings)

EIN.: 043505116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30347 | Film No.: 23813783
SIC: 2836 Biological Products, (No Diagnostic Substances)